November 2025
Core topics in this month’s edition include:
- FreeStyle Libre® 3 and FreeStyle Libre 3 Plus Sensors - Drug Recall
- Itvisma® (onasemnogene abeparvovec-brve) – New orphan drug approval
- Opdivo Qvantig™ (nivolumab/hyaluronidase-nvhy) – New formulation approval